Penicillin-(cloxacillin-) resistant mutants of Bacillus subtilis were isolated in a stepwise fashion and the five penicillin-binding components (PBCs) in each were examined to determine which of the proteins, if any, corresponds to the penicillin killing site. PBCs III and V were previously eliminated as the likely penicillin target. In the present work, PBC IV showed no change in sensitivity to cloxacillin in any of the resistant mutants isolated. PBC I did not change until the fifth-step mutant, in which it could not be detected by penicillin binding. Since PBC I did not bind penicillins that are lethal for this mutant, it also cannot be the lethal target. PBC II showed increased resistance to cloxaciffin in three discrete steps, i.e., in mutants 1, 4, and 5, accompanied by changes in its electrophoretic mobility. However, the sensitivity of PBC II to penicillin C changed very little. Correspondingly, the cloxacillinresistant mutants were unaltered in their sensitivity to penicillin G in vivo. (12).
come more resistant to penicillin upon mutation of the organism to greater penicillin resistance.
Bacillus subtilis has five penicillin-binding components which can be easily isolated from solubilized membranes by affinity chromatography (8) (9) (10) . Of the five, only PBC V has so far been found to possess enzymatic activity. It is the D-alanine carboxypeptidase and represents at least 80% of the penicillin-binding protein both in the membranes and in the purified PBCs (8, 11) . Since this enzyme is not essential to normal growth in B. subtilis it is not a penicillin killing site (11) . In addition, PBC III is not a killing site because it binds penicillin only at very high concentrations (9) . On the other hand, PBCs I, II, and IV are all candidates for the penicillin killing site, since their antibiotic sensitivity profiles closely resemble that of the killing site (9) . Thus, the present study has concentrated on changes that might occur in PBCs I, II, and IV in penicillinresistant mutants of B. subtilis.
MATERIALS AND METHODS Organism and Isolation of Mutants. B. subtilis strain Porton, resistant to 5 ,ug/ml of rifampicin and 200 /.g/ml of streptomycin, was used as the wild type. Penicillin sensitivity was determined by counting colonies on Antibiotic Medium 3 (Difco) agar plates containing various concentrations of the antibiotic at 30. To isolate a resistant mutant, a colony growing on a plate containing a high concentration of cloxacillin (E. R. Squibb & Sons, Inc.) was picked and purified by two rounds of single colony isolation. No mutagens were used. Cell-bound penicillinase activity was assayed as described (12) .
Preparation of Membranes and Isolation of PBCs. Membranes were prepared by grinding cells with glass beads as described previously (9) . The penicillin-binding components were isolated by affinity chromatography as described (10) except the Sepharose 4B200 (Sigma) was coupled with 6-aminohexanoic acid (Aldrich) prior to 6-aminopenicillanic acid (6-APA) (Sigma) substitution.
Penicillin Binding Assays.
[14C]Penicillin G (AmershamSearle, 53 mCi/mmol) was bound to B. subtilis membranes as described (9) . Sensitivity of the purified PBCs to a variety of penicillins was measured by first prebinding with an unlabeled penicillin at different concentrations and then adding a saturating concentration of [14C]penicillin G. The protocol was similar to that described elsewhere (8) . The binding reaction was stopped by adding a 250-fold excess of unlabeled penicillin G, followed by precipitation of the protein with 80% acetone. The protein precipitate was dried with a stream of air, boiled in sample buffer (see below), and applied to a gel.
Sodium Dodecyl Sulfate (NaDodSO4) Polyacrylamide Gel Electrophoresis. Tube gels were run as described by Weber and Osborn (13) . The gels were 8 cm long and subjected to electrophoresis for 6 hr at 8 mA per gel. Discontinuous NaDodSO4 polyacrylamide slab gels (2 mm) were run as described (14, 15 Isolation of PBCs by Affinity Chromatography. Two interesting alterations were evident in stained NaDodSO4 gels of the PBCs purified by affinity chromatography (Fig. 2) (Fig. 3) . The pattern clearly indicates that PBC II of mutant 5 is not identical to that of the wild type. Another slight alteration in PBC II may have occurred in mutant 1. Such small changes in electrophoretic mobility could be the result of a single amino acid change affecting the charge on the protein (20, 21) . Examination of PBC II is further complicated by the fact that in some gels it appears to be two proteins. Further studies using higher resolution gel systems are necessary.
PBCs III, IV, and V were present in all the organisms and no gross differences were seen among the preparations. PBC III consistently appeared as a doublet on slab gels, which was not observed previously or in the present work when the PBCs were run on tube gels. The lower half of the doublet was very resistant to penicillin, as was previously described (9) . The higher molecular weight half of the doublet, on the other hand, was extremely sensitive to all penicillins tested in all of the mutants and the wild type.
Kinetics of Cloxacillin Binding to PBCs I, II, and IV. Since radioactive cloxacillin was not available, cloxacillin binding was measured indirectly by competition for subsequent binding of labeled penicillin G (Fig. 4) . The concentrations of cloxacillin (,gg/ml) used multiplied times the time of exposure to the antibiotic in minutes range from 0 to 500 in the experiment illustrated. PBC I, totally absent in mutant 5, was no more resistant to cloxacillin in mutant 4 than in the wild type. PBC IV was unaltered in its cloxacillin sensitivity in all of the mutants. PBC II was markedly increased in cloxacillin resistance in both mutants 4 levels of the organisms (Fig. 1) . PBC IV retained the same sensitivity to cloxacillin as the wild type in all five mutants. Preliminary measurements with oxacillin and dicloxacillin suggested a similar pattern of changes (data not shown).
The affinity of the wild-type and mutant 5 PBCs for penicillin G was also measured. There was no significant change in the sensitivity of either PBC II or PBC IV from the mutant (Fig.  6) . DISCUSSION It is clear from these studies that the selection of penicillinresistant mutants of Bacillus subtilis is accompanied by alterations in the penicillin-binding components of this organism. The change in sensitivity of PBC II to cloxacillin appeared to occur in three discrete steps, i.e., in mutants 1, 4, and 5. In mutant 4, and possibly in mutant 1, the change was accompanied by a change in electrophoretic mobility, while in mutant 5 the altered resistance was manifested only by an altered sensitivity to cloxacillin. Earlier a single-step mutant of B. subtilis showing a small change in resistance to 6-APA was isolated; in that mutant also, only PBC II exhibited a significant, reproducible decrease in its affinity for 6-APA (22) . Direct proof of the relationship between the altered penicillin-binding component and altered penicillin sensitivity could be obtained by isolating a revertant in which both properties were reverted; however, it is not possible to select for such a revertant. Alternatively, this problem might be resolved by genetic experiments involving transformation of B. subtilis.
There was no apparent change in PBC II or any other PBC in mutants 2 and 3. Some other change must have occurred in these mutants, possibly a membrane change reflected in altered permeability rather than in an alteration in one of the PBCs. Increased production of a cell-bound penicillinase in any of the mutants was ruled out (data not shown).
A remarkable fact is that the alteration in sensitivity of mutant 5 to cloxacillin was accompanied by little or no change in the organism's sensitivity to penicillin G. Correspondingly, there was little or no change in the sensitivity of PBC II to penicillin G despite the obvious alteration of the protein's electrophoretic mobility. This indicates that the active sites of penicillin-sensitive proteins may be modified in their sensitivity to one 0-lactam antibiotic without any alteration in sensitivity to others. This fact may have implications for therapy with fl-lactam antibiotics and it is paralleled by wide differences in the sensitivity of PBCs in wild-type organisms to different f3-lactam antibiotics. A striking example of this is the extreme sensitivity of PBC II in E. coli to formamidino penicillin as compared to all other penicillins that have been examined (7) .
The loss of the penicillin-binding activity of PBC I that occurred during isolation of mutant 5 is an interesting finding. PBC II 1.0 .96 In addition, PBC IV cannot be the lethal target of cloxacillin, at least, since it did not change in its affinity for cloxacillin in any of the five cloxacillin-resistant mutants. As discussed above, PBC I and PBC V are also eliminated. One of the proteins of the PBC III doublet is too insensitive to be the killing site, and the other is far too sensitive. Thus, all the evidence points to PBC II as the likely target for killing of B. subtilis by f3-lactam antibiotics.
The function of the various penicillin-binding components of B. subtilis remains an important unsolved problem. It may be imagined that these proteins are all enzymes that may participate in different aspects of cell wall synthesis, such as elongation, septation, and formation of "corners" of rods. Further study of mutants in which these PBCs are altered may shed light on these functions, and, certainly, isolation of the individual PBCs in a pure form is an important objective.
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